Skip to main content

CymaBay Therapeutics, Inc.

CBAYDelisted Mar 22, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001042074

CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in CymaBay Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
151
+12 vs. Q1 2023
Shares held
92.9M
+4.03M (+4.5%) vs. Q1 2023
Total value
$1.02B
+$241.9M (+31.2%) vs. Q1 2023
New holders
45
42 more added
Sold out
33
39 more reduced

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CBAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 151 institutions
Q1 2021: 130 institutionsQ2 2021: 113 institutionsQ3 2021: 114 institutionsQ4 2021: 113 institutionsQ1 2022: 118 institutionsQ2 2022: 106 institutionsQ3 2022: 100 institutionsQ4 2022: 118 institutionsQ1 2023: 140 institutionsQ2 2023: 151 institutionsQ3 2023: 189 institutionsQ4 2023: 200 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $1.02B
Q1 2021: $251.7MQ2 2021: $227.4MQ3 2021: $169.3MQ4 2021: $215.7MQ1 2022: $202.8MQ2 2022: $185.9MQ3 2022: $217.9MQ4 2022: $404.2MQ1 2023: $774.9MQ2 2023: $1.02BQ3 2023: $1.61BQ4 2023: $2.71BQ1 2024: $21.1KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CBAY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$21.1K
Q4 2023200$2.71B
Q3 2023189$1.61B
Q2 2023151$1.02B
Q1 2023140$774.9M
Q4 2022118$404.2M
Q3 2022100$217.9M
Q2 2022106$185.9M
Q1 2022118$202.8M
Q4 2021113$215.7M
Q3 2021114$169.3M
Q2 2021113$227.4M
Q1 2021130$251.7M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding CymaBay Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding CBAY in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Laurion Capital Management LP214,356$2.35M0.10%−1,707,747−88.8%Reduced
Walleye Capital LLC234,643$2.57M0.05%+234,643New
Prudential Financial Inc241,110$2.64M0.00%+241,110New
Charles Schwab Investment Management Inc264,734$2.90M0.00%+226,254+588.0%Added
Renaissance Technologies LLC270,020$2.96M0.00%−211,480−43.9%Reduced
Woodline Partners LP285,717$3.13M0.04%00.0%Unchanged
Nuveen Asset Management, LLC298,875$3.27M0.00%+298,875New
HighVista Strategies LLC338,842$3.71M1.70%−8,944−2.6%Reduced
EAM Investors, LLC372,624$4.08M0.76%+56,030+17.7%Added
Soleus Capital Management, L.P.373,000$4.08M0.45%+373,000New
Bank of New York Mellon Corp377,487$4.13M0.00%+337,506+844.2%Added
Voloridge Investment Management, LLC382,472$4.19M0.02%−261,340−40.6%Reduced
JPMorgan Chase & Co423,461$4.64M0.00%−118,946−21.9%Reduced
Acuta Capital Partners, LLC430,000$4.71M3.19%−448,500−51.1%Reduced
Citadel Advisors LLC449,462$4.92M0.01%+123,576+37.9%Added
Versant Venture Management, LLC543,753$5.95M7.06%00.0%Unchanged
Nantahala Capital Management, LLC553,307$6.06M0.74%−1,236,796−69.1%Reduced
Opaleye Management Inc.566,700$6.21M1.48%+566,700New
Goldman Sachs Group Inc573,145$6.28M0.00%−200,201−25.9%Reduced
Altium Capital Management LP668,702$7.32M5.73%+48,702+7.9%Added
D. E. Shaw & Co., Inc.692,401$7.58M0.01%+143,357+26.1%Added
Nicholas Investment Partners, LP696,947$7.63M0.52%+696,947New
Marshall Wace, LLP781,735$8.56M0.02%+538,554+221.5%Added
Morgan Stanley823,699$9.02M0.00%−168,682−17.0%Reduced
Deutsche Bank AG825,957$9.04M0.00%+430,868+109.1%Added
Two Sigma Investments, LP875,888$9.59M0.03%−543,652−38.3%Reduced
Invesco Ltd.922,019$10.1M0.00%−32,608−3.4%Reduced
Northern Trust Corp975,399$10.7M0.00%+765,922+365.6%Added
Affinity Asset Advisors, LLC1,050,118$11.5M4.53%−33,000−3.0%Reduced
Two Sigma Advisers, LP1,156,438$12.7M0.03%−258,400−18.3%Reduced
Dimensional Fund Advisors LP1,167,413$12.8M0.00%−15,823−1.3%Reduced
Saturn V Capital Management LLC1,187,801$13.0M7.21%−441,663−27.1%Reduced
Lynx1 Capital Management LP1,205,050$13.2M8.65%−164,877−12.0%Reduced
Millennium Management LLC1,443,994$15.8M0.02%−1,505,062−51.0%Reduced
Jennison Associates LLC1,671,532$18.3M0.02%+1,047,869+168.0%Added
Balyasny Asset Management LLC1,714,818$18.8M0.05%−242,250−12.4%Reduced
Foresite Capital Management IV, LLC1,787,094$19.6M9.62%00.0%Unchanged
Geode Capital Management, LLC1,855,470$20.3M0.00%+950,512+105.0%Added
Novo Holdings A/S2,000,000$21.9M1.69%+2,000,000New
Commodore Capital LP2,025,000$22.2M2.49%00.0%Unchanged
State Street Corp2,308,493$25.3M0.00%+1,639,457+245.0%Added
Bain Capital Life Sciences Investors, LLC2,500,000$27.4M2.82%00.0%Unchanged
Franklin Resources Inc3,272,008$35.8M0.02%+47,146+1.5%Added
Perceptive Advisors LLC3,733,255$40.9M1.19%−170,000−4.4%Reduced
Cormorant Asset Management, LP3,800,000$41.6M2.37%+2,528,571+198.9%Added
Adage Capital Partners GP, L.L.C.4,401,292$48.2M0.10%+1,8920.0%Added
Octagon Capital Advisors LP4,570,918$50.1M6.98%00.0%Unchanged
Vanguard Group Inc5,148,880$56.4M0.00%+699,272+15.7%Added
BlackRock Inc.7,504,670$82.2M0.00%+4,854,593+183.2%Added
Janus Henderson Group PLC7,746,587$84.8M0.05%+250,538+3.3%Added
Avoro Capital Advisors LLC10,300,000$112.8M1.53%00.0%Unchanged
TCG Crossover Management, LLC0$00.00%−3,048,257−100.0%Sold out
Great Point Partners LLC0$00.00%−507,500−100.0%Sold out
683 Capital Management, LLC0$00.00%−500,000−100.0%Sold out
Logos Global Management LP0$00.00%−400,000−100.0%Sold out
HRT Financial LP0$00.00%−385,676−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−266,400−100.0%Sold out
Wellington Management Group LLP0$00.00%−152,487−100.0%Sold out
Carlyle Group Inc.0$00.00%−131,036−100.0%Sold out
Verition Fund Management LLC0$00.00%−100,342−100.0%Sold out
Harvest Investment Services, LLC0$00.00%−76,956−100.0%Sold out
LMR Partners LLP0$00.00%−66,251−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−58,180−100.0%Sold out
Bamco Inc0$00.00%−44,206−100.0%Sold out
Diametric Capital, LP0$00.00%−33,706−100.0%Sold out
Caxton Associates LP0$00.00%−25,725−100.0%Sold out
First Manhattan Co0$00.00%−25,000−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−20,597−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−19,687−100.0%Sold out
Point72 Middle East FZE0$00.00%−19,618−100.0%Sold out
Man Group plc0$00.00%–Sold out
Jefferies Financial Group Inc.0$00.00%−17,899−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−17,468−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−16,249−100.0%Sold out
Algert Global LLC0$00.00%−15,080−100.0%Sold out
Bank of Nova Scotia0$00.00%−13,554−100.0%Sold out
Lake Street Financial LLC0$00.00%−12,900−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−10,973−100.0%Sold out
Lighthouse Investment Partners, LLC0$00.00%−10,092−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−500−100.0%Sold out
US Bancorp0$00.00%−360−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−341−100.0%Sold out
Creative Planning0$00.00%−231−100.0%Sold out
Parallel Advisors, LLC0$00.00%−41−100.0%Sold out
CTC Capital Management, LLC––––Not filed